CONNECT WITH US
HealthTech

HealthTech

UK lands £500M in biopharma pledges; Teva to shutter New Jersey site

Endpoints News logo

Published on

Add as a preferred source on Google
UK lands £500M in biopharma pledges; Teva to shutter New Jersey site

UK lands £500M in bio­phar­ma pledges; Te­va to shut­ter New Jer­sey site

UK pulls in £500M in­vest­ment: As part of the UK’s Au­tumn bud­get, Ver­tex Phar­ma­ceu­ti­cals said it will in­vest over …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Cit­ing 'safe­ty' and 'free­dom,' HHS will al­low com­pound­ing of cer­tain well­ness pep­tides October 28, 2026

Pfiz­er In­dia site clo­sure risks ex­ac­er­bat­ing can­cer drug short­ages October 28, 2026

WuXi AppTec rais­es rev­enue fore­cast again in the face of DOD court case October 26, 2026

One-per­son biotechs and an 'age of mir­a­cles': An­throp­ic re­veals next leg of its bio­phar­ma vi­sion

Up­dat­ed: Lil­ly beats rev­enue fore­casts, lift­ing full-year out­look for third straight quar­ter

Ex­clu­sive: Dren Bio nabs $350M for po­ten­tial 2027 launch of blood can­cer drug



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.